Multiple Sclerosis Immunotherapy Clinical Trial Expands to United States – Specialty Pharmacy Times
|
Multiple Sclerosis Immunotherapy Clinical Trial Expands to United States
Specialty Pharmacy Times Atara Biotherapeutics recently announced it received FDA clearance to start enrolling patients in a clinical trial evaluating an experimental immunotherapy for multiple sclerosis (MS), according to a press release. The new phase 1 clinical trial will … |
